PIM1 expression was examined in 134 NSCLC patients (56 adenocarcinomas, 65 squamous cell carcinomas and 13 of other histology) of various stages (I–IV) by immunohistochemical analysis (Table S1). The gene discussed is PIM1; the disease is adenocarcinoma.